Europe Clinical Trials Market
Historic Data:    |   Base Year: 2023   |   Forecast Period: 2024-2031
Forecast to 2028 - Regional Analysis - by Study Design (Interventional, Observational, and Expanded Access), Phase (Phase I, Phase II, Phase III, and Phase IV), and Indication (Autoimmune/Inflammation, Pain Management, Oncology, CNS Condition, Diabetes, Obesity, Cardiovascular, and Others)

No. of Pages: 148    |    Report Code: BMIRE00028989    |    Category: Life Sciences

Available Report Formats

pdf-format excel-format pptx-format
Request Free Sample Buy Now
Europe Clinical Trials Market

1.           Introduction

1.1         Scope of the Study

1.2         The Insight Partners Research Report Guidance

1.3         Market Segmentation

1.3.1        Europe Clinical Trials Market – By Phase

1.3.2        Europe Clinical Trials Market – By Study Design

1.3.3        Europe Clinical Trials Market – By Indication

1.3.4        Europe Clinical Trials Market – By Country

2.           Key Takeaways

3.        Research Methodology

3.1         Coverage

3.2         Secondary Research

3.3         Primary Research

4.           Europe Clinical Trials Market – Market Landscape

4.1         Overview

4.2         PEST Analysis

4.2.1        Europe PEST Analysis

4.3         Experts Opinion

5.           Europe Clinical Trials Market – Key Market Dynamics

5.1         Market Drivers

5.1.1        Increasing Adoption and Outsourcing of Clinical Trials

5.1.2        Flourishing Pharmaceutical Industry and Increasing R&D Activities in Pharmaceutical Industry

5.2         Market Restraints

5.2.1        Expensive and Time-Consuming Process

5.3         Market Opportunities

5.3.1        Adoption of Decentralized Clinical Trials and Hybrid Clinical Trials

5.4         Future Trends

5.4.1        AI-Driven Clinical Trials

5.5         Impact Analysis

6.           Clinical Trials Market – Europe Analysis

6.1         Europe Clinical Trials Market Revenue Forecast and Analysis

7.           Europe Clinical Trials Market Revenue and Forecast To 2028 – by Study Design

7.1         Overview

7.2         Europe Clinical Trials Market Revenue Share, by Study Design (2022 and 2028)

7.3         Interventional

7.3.1        Overview

7.3.2        Interventional: Europe Clinical Trials Market – Revenue and Forecast to 2028 (US$ Million)

7.4         Observational

7.4.1        Overview

7.4.2        Observational: Europe Clinical Trials Market – Revenue and Forecast to 2028 (US$ Million)

7.5         Expanded Access

7.5.1        Overview

7.5.2        Expanded Access: Europe Clinical Trials Market – Revenue and Forecast to 2028 (US$ Million)

8.           Europe Clinical Trials Market – By Phase

8.1         Overview

8.2         Europe Clinical Trials Market, by Phase, 2022 and 2028 (%)

8.3         Phase III

8.3.1        Overview

8.3.2        Phase III: Europe Clinical Trials Market – Revenue and Forecast to 2028 (US$ Million)

8.4         Phase II

8.4.1        Overview

8.4.2        Phase II: Europe Clinical Trials Market – Revenue and Forecast to 2028 (US$ Million)

8.5         Phase IV

8.5.1        Overview

8.5.2        Phase IV: Europe Clinical Trials Market – Revenue and Forecast to 2028 (US$ Million)

8.6         Phase I

8.6.1        Overview

8.6.2        Phase I: Europe Clinical Trials Market – Revenue and Forecast to 2028 (US$ Million)

9.           Europe Clinical Trials Market Revenue and Forecast To 2028 – Indication

9.1         Overview

9.2         Europe Clinical Trials Market Revenue Share, by Indication (2022 and 2028)

9.3         Autoimmune/Inflammation

9.3.1        Overview

9.3.2        Autoimmune/Inflammation: Europe Clinical Trials Market – Revenue and Forecast to 2028 (US$ Million)

9.4         Pain Management

9.4.1        Overview

9.4.2        Pain Management: Europe Clinical Trials Market – Revenue and Forecast to 2028 (US$ Million)

9.5         Oncology

9.5.1        Overview

9.5.2        Oncology: Europe Clinical Trials Market – Revenue and Forecast to 2028 (US$ Million)

9.6         CNS Condition

9.6.1        Overview

9.6.2        CNS Condition: Europe Clinical Trials Market – Revenue and Forecast to 2028 (US$ Million)

9.7         Diabetes

9.7.1        Overview

9.7.2        Diabetes: Europe Clinical Trials Market – Revenue and Forecast to 2028 (US$ Million)

9.8         Obesity

9.8.1        Overview

9.8.2        Obesity: Europe Clinical Trials Market – Revenue and Forecast to 2028 (US$ Million)

9.9         Cardiovascular

9.9.1        Overview

9.9.2        Cardiovascular: Europe Clinical Trials Market – Revenue and Forecast to 2028 (US$ Million)

9.10      Other

9.10.1     Overview

9.10.2     Other: Europe Clinical Trials Market – Revenue and Forecast to 2028 (US$ Million)

10.        Europe Clinical Trials Market – Revenue and Forecast to 2028 – Country Analysis

10.1      Europe: Clinical Trials Market

10.1.1     Overview

10.1.2     Europe: Clinical Trials Market, by Country, 2022 & 2028 (%)

10.1.2.1       Germany: Clinical Trials Market – Revenue and Forecast to 2028 (US$ Million)

10.1.2.1.1       Overview

10.1.2.1.2       Germany: Clinical Trials Market – Revenue and Forecast to 2028 (US$ Million)

10.1.2.1.3       Germany: Clinical Trials Market, by Phase, 2020-2028 (US$ Million)

10.1.2.1.4       Germany: Clinical Trials Market, by Study Design, 2020-2028 (US$ Million)

10.1.2.1.5       Germany: Clinical Trials Market, by Indication, 2020-2028 (US$ Million)

10.1.2.2       UK: Clinical Trials Market – Revenue and Forecast to 2028 (US$ Million)

10.1.2.2.1       Overview

10.1.2.2.2       UK: Clinical Trials Market – Revenue and Forecast to 2028 (US$ Million)

10.1.2.2.3       UK: Clinical Trials Market, by Phase, 2020-2028 (US$ Million)

10.1.2.2.4       UK: Clinical Trials Market, by Study Design, 2020-2028 (US$ Million)

10.1.2.2.5       UK: Clinical Trials Market, by Indication, 2020-2028 (US$ Million)

10.1.2.3       France: Clinical Trials Market – Revenue and Forecast to 2028 (US$ Million)

10.1.2.3.1       Overview

10.1.2.3.2       France: Clinical Trials Market – Revenue and Forecast to 2028 (US$ Million)

10.1.2.3.3       France: Clinical Trials Market, by Phase, 2020-2028 (US$ Million)

10.1.2.3.4       France: Clinical Trials Market, by Study Design, 2020-2028 (US$ Million)

10.1.2.3.5       France: Clinical Trials Market, by Indication, 2020-2028 (US$ Million)

10.1.2.4       Italy: Clinical Trials Market – Revenue and Forecast to 2028 (US$ Million)

10.1.2.4.1       Overview

10.1.2.4.2       Italy: Clinical Trials Market – Revenue and Forecast to 2028 (US$ Million)

10.1.2.4.3       Italy: Clinical Trials Market, by Phase, 2020-2028 (US$ Million)

10.1.2.4.4       Italy: Clinical Trials Market, by Study Design, 2020-2028 (US$ Million)

10.1.2.4.5       Italy: Clinical Trials Market, by Indication, 2020-2028 (US$ Million)

10.1.2.5       Spain: Clinical Trials Market – Revenue and Forecast to 2028 (US$ Million)

10.1.2.5.1       Overview

10.1.2.5.2       Spain: Clinical Trials Market – Revenue and Forecast to 2028 (US$ Million)

10.1.2.5.3       Spain: Clinical Trials Market, by Phase, 2020-2028 (US$ Million)

10.1.2.5.4       Spain: Clinical Trials Market, by Study Design, 2020-2028 (US$ Million)

10.1.2.5.5       Spain: Clinical Trials Market, by Indication, 2020-2028 (US$ Million)

10.1.2.6       Rest of Europe: Clinical Trials Market – Revenue and Forecast to 2028 (US$ Million)

10.1.2.6.1       Overview

10.1.2.6.2       Rest of Europe: Clinical Trials Market – Revenue and Forecast to 2028 (US$ Million)

10.1.2.6.3       Rest of Europe: Clinical Trials Market, by Phase, 2020-2028 (US$ Million)

10.1.2.6.4       Rest of Europe: Clinical Trials Market, by Study Design, 2020-2028 (US$ Million)

10.1.2.6.5       Rest of Europe: Clinical Trials Market, by Indication, 2020-2028 (US$ Million)

11.        Industry Landscape

11.1      Overview

11.2      Growth Strategies Done by the Companies in the Market, (%)

11.3      Organic Developments

11.3.1     Overview

11.4      Inorganic Developments

11.4.1     Overview

12.        Company Profiles

12.1      IQVIA Holdings Inc

12.1.1     Key Facts

12.1.2     Business Description

12.1.3     Products and Services

12.1.4     Financial Overview

12.1.5     SWOT Analysis

12.1.6     Key Developments

12.2      Parexel International Corp

12.2.1     Key Facts

12.2.2     Business Description

12.2.3     Products and Services

12.2.4     Financial Overview

12.2.5     SWOT Analysis

12.2.6     Key Developments

12.3      IXICO Plc

12.3.1     Key Facts

12.3.2     Business Description

12.3.3     Products and Services

12.3.4     Financial Overview

12.3.5     SWOT Analysis

12.3.6     Key Developments

12.4      Charles River Laboratories International Inc

12.4.1     Key Facts

12.4.2     Business Description

12.4.3     Products and Services

12.4.4     Financial Overview

12.4.5     SWOT Analysis

12.4.6     Key Developments

12.5      ICON Plc

12.5.1     Key Facts

12.5.2     Business Description

12.5.3     Products and Services

12.5.4     Financial Overview

12.5.5     SWOT Analysis

12.5.6     Key Developments

12.6      WuXi AppTec Co Ltd

12.6.1     Key Facts

12.6.2     Business Description

12.6.3     Products and Services

12.6.4     Financial Overview

12.6.5     SWOT Analysis

12.6.6     Key Developments

12.7      SGS SA

12.7.1     Key Facts

12.7.2     Business Description

12.7.3     Products and Services

12.7.4     Financial Overview

12.7.5     SWOT Analysis

12.7.6     Key Developments

12.8      Syneos Health Inc

12.8.1     Key Facts

12.8.2     Business Description

12.8.3     Products and Services

12.8.4     Financial Overview

12.8.5     SWOT Analysis

12.8.6     Key Developments

12.9      Thermo Fisher Scientific Inc

12.9.1     Key Facts

12.9.2     Business Description

12.9.3     Products and Services

12.9.4     Financial Overview

12.9.5     SWOT Analysis

12.9.6     Key Developments

12.10   Laboratory Corp of America Holdings

12.10.1  Key Facts

12.10.2  Business Description

12.10.3  Products and Services

12.10.4  Financial Overview

12.10.5  SWOT Analysis

12.10.6  Key Developments

13.        Appendix

13.1      About The Insight Partners

13.2      Glossary of Terms

 

LIST OF TABLES

Table 1.             Germany: Clinical Trials Market, by Phase – Revenue and Forecast to 2028 (US$ Million)

Table 2.             Germany: Clinical Trials Market, by Study Design – Revenue and Forecast to 2028 (US$ Million)

Table 3.             Germany: Clinical Trials Market, by Indication – Revenue and Forecast to 2028 (US$ Million)

Table 4.             UK Clinical Trials Market, by Phase – Revenue and Forecast to 2028 (US$ Million)

Table 5.             UK Clinical Trials Market, by Study Design – Revenue and Forecast to 2028 (US$ Million)

Table 6.             UK Clinical Trials Market, by Indication – Revenue and Forecast to 2028 (US$ Million)

Table 7.             France: Clinical Trials Market, by Phase – Revenue and Forecast to 2028 (US$ Million)

Table 8.             France: Clinical Trials Market, by Study Design – Revenue and Forecast to 2028 (US$ Million)

Table 9.             France: Clinical Trials Market, by Indication – Revenue and Forecast to 2028 (US$ Million)

Table 10.          Italy: Clinical Trials Market, by Phase – Revenue and Forecast to 2028 (US$ Million)

Table 11.          Italy: Clinical Trials Market, by Study Design – Revenue and Forecast to 2028 (US$ Million)

Table 12.          Italy: Clinical Trials Market, by Indication – Revenue and Forecast to 2028 (US$ Million)

Table 13.          Spain: Clinical Trials Market, by Phase – Revenue and Forecast to 2028 (US$ Million)

Table 14.          Spain: Clinical Trials Market, by Study Design – Revenue and Forecast to 2028 (US$ Million)

Table 15.          Spain: Clinical Trials Market, by Indication – Revenue and Forecast to 2028 (US$ Million)

Table 16.          Rest of Europe: Clinical Trials Market, by Phase – Revenue and Forecast to 2028 (US$ Million)

Table 17.          Rest of Europe: Clinical Trials Market, by Study Design – Revenue and Forecast to 2028 (US$ Million)

Table 18.          Rest of Europe: Clinical Trials Market, by Indication – Revenue and Forecast to 2028 (US$ Million)

Table 19.          Organic Developments Done by Companies

Table 20.          Inorganic Developments Done by Companies

Table 21.          Glossary of Terms

 

 

LIST OF FIGURES

Figure 1.           Europe Clinical Trials Market Segmentation

Figure 2.           Europe Clinical Trials Market, By Region

Figure 3.           Europe Clinical Trials Market Overview

Figure 4.           Phase III Segment Held Largest Share of Phase Segment in Europe Clinical Trials Market

Figure 5.           The UK is Expected to Show Remarkable Growth During the Forecast Period

Figure 6.           Europe: PEST Analysis

Figure 7.           Europe Experts Opinion

Figure 8.           Impact Analysis

Figure 9.           Europe Clinical Trials Market– Revenue Forecast and Analysis – 2020- 2028

Figure 10.        Europe Clinical Trials Market Revenue Share, by Study Design (2022 and 2028)

Figure 11.        Interventional: Europe Clinical Trials Market – Revenue and Forecast to 2028 (US$ Million)

Figure 12.        Observational: Europe Clinical Trials Market – Revenue and Forecast to 2028 (US$ Million)

Figure 13.        Expanded Access: Europe Clinical Trials Market – Revenue and Forecast to 2028 (US$ Million)

Figure 14.        Europe Clinical Trials Market, by Phase 2022 and 2028 (%)

Figure 15.        Phase III: Europe Clinical Trials Market – Revenue and Forecast to 2028 (US$ Million)

Figure 16.        Phase II: Europe Clinical Trials Market – Revenue and Forecast to 2028 (US$ Million)

Figure 17.        Phase IV: Europe Clinical Trials Market – Revenue and Forecast to 2028 (US$ Million)

Figure 18.        Phase I: Europe Clinical Trials Market – Revenue and Forecast to 2028 (US$ Million)

Figure 19.        Europe Clinical Trials Market Revenue Share, by Indication (2022 and 2028)

Figure 20.        Autoimmune/Inflammation: Europe Clinical Trials Market – Revenue and Forecast to 2028 (US$ Million)

Figure 21.        Pain Management: Europe Clinical Trials Market – Revenue and Forecast to 2028 (US$ Million)

Figure 22.        Oncology: Europe Clinical Trials Market – Revenue and Forecast to 2028 (US$ Million)

Figure 23.        CNS Condition: Europe Clinical Trials Market – Revenue and Forecast to 2028 (US$ Million)

Figure 24.        Diabetes: Europe Clinical Trials Market – Revenue and Forecast to 2028 (US$ Million)

Figure 25.        Obesity: Europe Clinical Trials Market – Revenue and Forecast to 2028 (US$ Million)

Figure 26.        Cardiovascular: Europe Clinical Trials Market – Revenue and Forecast to 2028 (US$ Million)

Figure 27.        Other: Europe Clinical Trials Market – Revenue and Forecast to 2028 (US$ Million)

Figure 28.        Europe: Clinical Trials Market, by Key Country – Revenue (2022) (US$ Million)

Figure 29.        Europe: Clinical Trials Market, by Country, 2022 & 2028 (%)

Figure 30.        Germany: Clinical Trials Market – Revenue and Forecast to 2028 (US$ Million)

Figure 31.        UK: Clinical Trials Market – Revenue and Forecast to 2028 (US$ Million)

Figure 32.        France: Clinical Trials Market – Revenue and Forecast to 2028 (US$ Million)

Figure 33.        Italy: Clinical Trials Market – Revenue and Forecast to 2028 (US$ Million)

Figure 34.        Spain: Clinical Trials Market – Revenue and Forecast to 2028 (US$ Million)

Figure 35.        Rest of Europe: Clinical Trials Market – Revenue and Forecast to 2028 (US$ Million)

Figure 36.        Growth Strategies Done by the Companies in the Market, (%) 

The List of Companies - Europe Clinical Trials Market

  1. Charles River Laboratories International Inc
  2. ICON Plc
  3. IQVIA Holdings Inc
  4. IXICO Plc
  5. Laboratory Corp of America Holdings
  6. Parexel International Corp
  7. SGS SA
  8. Syneos Health Inc
  9. Thermo Fisher Scientific Inc
  10. WuXi AppTec Co Ltd